<p>The qLAMP-based diagnostic rates in LRTI patients and different subgroups.</p
<p>Rate of secondary diagnoses recorded in HES and found in research diagnosis.</p
<p>Numbers in parentheses indicate patients at risk at beginning of each time interval (the front nu...
The Q-Q plots of patient group and health group for biomarkers TEOAE and ABR.</p
<p>(A) The positive rates (the right vertical axis) of one-time culture (brown bar), three-time cult...
<p>Clinical and demographic data for HER2-amplified luminal and ordinary-luminal patients.</p
<p>Diagnoses of patients in 120-kVp (protocol A) and 80-kVp (protocol B and protocol C).</p
<p>Summary of clinical information and mutation detection rates for subgroups of the cohort.</p
Positivity rates of the three diagnostic methods used for the 114 sampled patients.</p
<p>Percentage of patients with abnormal LSM values according to cutoff values of the cumulative expo...
<p>LTBI test results and percentages of patients who received LTBI treatment among 476 patients.</p
<p>Details and summary of the diagnostic performance of different studies using LAMP for VL diagnosi...
<p>Patient based comparison of cancer detection rate between systematic biopsy group and targeted bi...
<p>Prevalence rates of LQTS among users and non-users of QT-interval prolonging drugs in the 24 hour...
<p>*Other symptoms included general malaise, abdominal pain and cough.</p><p>Quantitative diagnostic...
<p>Clinical and electrophysiological characteristics, and additional tests results in total cohort, ...
<p>Rate of secondary diagnoses recorded in HES and found in research diagnosis.</p
<p>Numbers in parentheses indicate patients at risk at beginning of each time interval (the front nu...
The Q-Q plots of patient group and health group for biomarkers TEOAE and ABR.</p
<p>(A) The positive rates (the right vertical axis) of one-time culture (brown bar), three-time cult...
<p>Clinical and demographic data for HER2-amplified luminal and ordinary-luminal patients.</p
<p>Diagnoses of patients in 120-kVp (protocol A) and 80-kVp (protocol B and protocol C).</p
<p>Summary of clinical information and mutation detection rates for subgroups of the cohort.</p
Positivity rates of the three diagnostic methods used for the 114 sampled patients.</p
<p>Percentage of patients with abnormal LSM values according to cutoff values of the cumulative expo...
<p>LTBI test results and percentages of patients who received LTBI treatment among 476 patients.</p
<p>Details and summary of the diagnostic performance of different studies using LAMP for VL diagnosi...
<p>Patient based comparison of cancer detection rate between systematic biopsy group and targeted bi...
<p>Prevalence rates of LQTS among users and non-users of QT-interval prolonging drugs in the 24 hour...
<p>*Other symptoms included general malaise, abdominal pain and cough.</p><p>Quantitative diagnostic...
<p>Clinical and electrophysiological characteristics, and additional tests results in total cohort, ...
<p>Rate of secondary diagnoses recorded in HES and found in research diagnosis.</p
<p>Numbers in parentheses indicate patients at risk at beginning of each time interval (the front nu...
The Q-Q plots of patient group and health group for biomarkers TEOAE and ABR.</p